ATE451918T1 - 7-carboxymethyloxy-3 , 4 , 5- trimethoxyflavonmonohydrat, herstellungsdverfahren dafür und seine verwendungen - Google Patents

7-carboxymethyloxy-3 , 4 , 5- trimethoxyflavonmonohydrat, herstellungsdverfahren dafür und seine verwendungen

Info

Publication number
ATE451918T1
ATE451918T1 AT04774508T AT04774508T ATE451918T1 AT E451918 T1 ATE451918 T1 AT E451918T1 AT 04774508 T AT04774508 T AT 04774508T AT 04774508 T AT04774508 T AT 04774508T AT E451918 T1 ATE451918 T1 AT E451918T1
Authority
AT
Austria
Prior art keywords
carboxymethyloxy
production method
hydroxy
trimethoxyflavone monohydrate
trimethoxyflavone
Prior art date
Application number
AT04774508T
Other languages
English (en)
Inventor
Moohi Yoo
Dong Sung Kim
Yong Duck Kim
Wonbae Kim
Original Assignee
Dong A Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dong A Pharm Co Ltd filed Critical Dong A Pharm Co Ltd
Application granted granted Critical
Publication of ATE451918T1 publication Critical patent/ATE451918T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
AT04774508T 2003-09-04 2004-09-04 7-carboxymethyloxy-3 , 4 , 5- trimethoxyflavonmonohydrat, herstellungsdverfahren dafür und seine verwendungen ATE451918T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020030061938A KR20050024121A (ko) 2003-09-04 2003-09-04 7-카르복시메틸옥시-3',4',5-트리메톡시 플라본.일수화물, 이의 제조방법 및 용도
PCT/KR2004/002247 WO2005023244A1 (en) 2003-09-04 2004-09-04 7-carboxymethyloxy-3', 4', 5-trimethoxy flavone monohydrate, the preparation method and uses thereof

Publications (1)

Publication Number Publication Date
ATE451918T1 true ATE451918T1 (de) 2010-01-15

Family

ID=36087516

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04774508T ATE451918T1 (de) 2003-09-04 2004-09-04 7-carboxymethyloxy-3 , 4 , 5- trimethoxyflavonmonohydrat, herstellungsdverfahren dafür und seine verwendungen

Country Status (19)

Country Link
US (1) US7371775B2 (de)
EP (2) EP1660074B1 (de)
JP (2) JP2007504217A (de)
KR (2) KR20050024121A (de)
CN (2) CN100591332C (de)
AT (1) ATE451918T1 (de)
AU (1) AU2004270065B2 (de)
BR (1) BRPI0413163A (de)
CA (1) CA2533301C (de)
DE (1) DE602004024687D1 (de)
DK (1) DK1660074T3 (de)
ES (1) ES2336000T3 (de)
MX (1) MXPA06002383A (de)
NZ (2) NZ575796A (de)
PT (1) PT1660074E (de)
RU (1) RU2302416C2 (de)
SG (1) SG136960A1 (de)
TR (2) TR200603833T2 (de)
WO (1) WO2005023244A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100930467B1 (ko) * 2007-06-07 2009-12-08 동아제약주식회사 점액분비를 촉진시키는 3',4',5-트리메톡시 플라본 유도체화합물, 그의 제조방법 및 약학적 용도
KR101381999B1 (ko) * 2007-07-06 2014-04-14 동아에스티 주식회사 위염 치료제의 효력을 극대화시키기 위한 가용화 위체류시스템 매트릭스 제제
US8350079B2 (en) * 2008-05-08 2013-01-08 United Therapeutics Corporation Treprostinil formulation
JP7121986B2 (ja) * 2018-08-16 2022-08-19 株式会社常磐植物化学研究所 アルコキシフラボン誘導体の製造方法
JP7467138B2 (ja) * 2020-01-30 2024-04-15 株式会社 資生堂 腸管バリア改善剤
US20250082603A1 (en) 2021-08-05 2025-03-13 Gl Pharmtech Corp. Ophthalmic composition containing recoflavone for the treatment of dry eye disease and method for preparing the same
CN117794515A (zh) 2021-08-05 2024-03-29 格里医药科技公司 用于治疗干眼综合征的包含瑞可黄酮的滴眼剂组合物及其制备方法
KR102356603B1 (ko) 2021-08-05 2022-02-08 지엘팜텍주식회사 안구건조증 치료를 위한 레코플라본 함유 점안 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623808B1 (fr) * 1987-12-01 1990-03-09 Adir Nouveaux derives flavonoides (benzyl-4 piperazinyl-1)-2 oxo-2 ethylene substitues, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
IT1245371B (it) * 1991-03-28 1994-09-20 Geymonat Spa Derivati di flavoni, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
US5399584A (en) * 1992-05-05 1995-03-21 The Procter & Gamble Company Use of flavone derivatives for gastroprotection
US5525072A (en) 1995-01-10 1996-06-11 Molex Incorporated Electrical connector assembly for interconnecting a flat cable to a circuit board
KR100447918B1 (ko) * 1996-07-25 2005-09-28 동아제약주식회사 대장을포함한위장관보호작용을갖는플라본및플라바논화합물
KR19990041205A (ko) 1997-11-21 1999-06-15 이종수 전자 브레이크장치
KR100327621B1 (ko) * 1999-09-22 2002-03-15 유충식 7-카르복시메틸옥시-3',4',5-트리메톡시플라본의 제조방법

Also Published As

Publication number Publication date
EP1660074A4 (de) 2008-02-27
US20060178428A1 (en) 2006-08-10
DE602004024687D1 (de) 2010-01-28
PT1660074E (pt) 2009-12-31
MXPA06002383A (es) 2006-06-20
CA2533301C (en) 2011-01-04
NZ544761A (en) 2009-10-30
RU2006102956A (ru) 2006-06-10
AU2004270065B2 (en) 2007-07-26
KR20050024121A (ko) 2005-03-10
CN101684113B (zh) 2012-05-23
SG136960A1 (en) 2007-11-29
US7371775B2 (en) 2008-05-13
KR100644928B1 (ko) 2006-11-15
HK1089962A1 (zh) 2006-12-15
NZ575796A (en) 2010-05-28
ES2336000T3 (es) 2010-04-07
TR200600987T1 (tr) 2007-01-22
DK1660074T3 (da) 2010-03-08
CN100591332C (zh) 2010-02-24
KR20050108369A (ko) 2005-11-16
EP2065375A1 (de) 2009-06-03
CA2533301A1 (en) 2005-03-17
TR200603833T2 (tr) 2006-11-21
EP1660074B1 (de) 2009-12-16
WO2005023244A1 (en) 2005-03-17
RU2302416C2 (ru) 2007-07-10
EP1660074A1 (de) 2006-05-31
JP2007504217A (ja) 2007-03-01
CN1822829A (zh) 2006-08-23
BRPI0413163A (pt) 2006-10-03
CN101684113A (zh) 2010-03-31
AU2004270065A1 (en) 2005-03-17
JP2010138193A (ja) 2010-06-24

Similar Documents

Publication Publication Date Title
EP1187216A4 (de) Herstellungsmethode einer verbundscheibe
EP1437327A4 (de) Verfahren zur herstellung von silicium
NZ594077A (en) Process for production of delta-9-tetrahydrocannabinol
EP1672067A4 (de) Verfahren zur herstellung einer organischen nicht-amino-säure
UA99896C2 (uk) Спосіб одержання глюкопіранозилзаміщених похідних бензилбензолу, проміжні продукти та способи їх одержання
EP1484384A4 (de) Verfahren zur herstellung von biokraftstoff
EP1528068A4 (de) Verfahren zur herstellung von soja protein
EP2157086A4 (de) Verfahren zur herstellung von glycosid-aglycon
EP1160229A4 (de) Verfahren zur herstellung von bisphenol a
EP1662555A4 (de) Verfahren zur herstellung eines soi-wafers
EP1538215A4 (de) Verfahren zur herstellung von lacton
ATE451918T1 (de) 7-carboxymethyloxy-3 , 4 , 5- trimethoxyflavonmonohydrat, herstellungsdverfahren dafür und seine verwendungen
EP1323352A4 (de) Verfahren zur herstellung von sojabohneneiweiss
EP1416051A4 (de) Verfahren zur herstellung von nikotinamid-adenin-dinukleotidphosphat (nadp)
EP1437326A4 (de) VERFAHREN ZUR HERSTELLUNG VON Si
BR0114437A (pt) Derivados de acido propiÈnico
EP1415967A4 (de) Verfahren zur herstellung von bisphenol-a
EP1614671A4 (de) Verfahren zur herstellung von isopren
EP1229011A4 (de) Ein verfahren zur herstellung von styrol
EP1721895A4 (de) Verfahren zur herstellung von cumenhydroperoxid
EP1679332A4 (de) Verfahren zur herstellung von aliphatischem polyester und aliphatischer polyester
DZ3111A1 (fr) Procédé de production des oléfines inferieures.
EP1496115A4 (de) Verfahren zur herstellung von canthaxanthin
EP1577315A4 (de) Herstellungsverfahren für polyphenol aus hopfenspelze
EP1816206A4 (de) Verfahren zur herstellung von uridin-5-diphospho-n-acetylgalactosamin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1660074

Country of ref document: EP